Table 5 Multivariate analysis of cancer-type specific mortality with metabolic syndrome by sex
| Â | Presence of MetS | Cancer deaths | Parson-years | Crude mortality (/1000 person-years) | HR-agea (95% CI) | HR-allb (95% CI) |
|---|---|---|---|---|---|---|
Men | ||||||
 Lung | No | 132 | 2374 | 1.8 | 1.00 | 1.00 |
Yes | 14 | 256 | 1.5 | 0.91 (0.52–1.58) | 1.13 (0.65–1.98) | |
 Stomach | No | 54 | 971 | 0.76 | 1.00 | 1.00 |
Yes | 9 | 162 | 0.96 | 1.35 (0.67–2.73) | 1.29 (0.58–2.88) | |
 Colon and rectum | No | 29 | 521 | 0.41 | 1.00 | 1.00 |
Yes | 4 | 72 | 0.42 | 1.16 (0.41–3.31) | 1.40 (0.48–4.10) | |
 Liver | No | 18 | 324 | 0.25 | 1.00 | 1.00 |
Yes | 4 | 72 | 0.42 | 1.86 (0.63–5.49) | 1.57 (0.45–5.53) | |
 Prostate | No | 12 | 216 | 0.17 | 1.00 | 1.00 |
Yes | 2 | 36 | 0.21 | 1.56 (0.35–6.99) | 1.41 (0.30–6.61) | |
Women | ||||||
 Lung | No | 30 | 565 | 0.25 | 1.00 | 1.00 |
Yes | 6 | 112 | 0.52 | 1.82 (0.76–4.37) | 1.66 (0.64–4.31) | |
 Stomach | No | 42 | 791 | 0.35 | 1.00 | 1.00 |
Yes | 5 | 94 | 0.43 | 1.09 (0.43–2.76) | 0.79 (0.24–2.57) | |
 Colon and rectum | No | 30 | 565 | 0.25 | 1.00 | 1.00 |
Yes | 10 | 187 | 0.86 | 3.07 (1.50–6.27) | 3.48 (1.68–7.22) | |
 Liver | No | 14 | 264 | 0.12 | 1.00 | 1.00 |
Yes | 3 | 56 | 0.26 | 1.97 (0.57–6.84) | 2.34 (0.66–8.28) | |
 Breast | No | 3 | 57 | 0.025 | 1.00 | 1.00 |
Yes | 3 | 56 | 0.26 | 10.70 (2.11–54.36) | 11.90 (2.25–62.84) | |